title: Changes in regulatory T cells after rituximab in two patients with refractory myasthenia gravis.
authors.forename: Valentina
authors.initials: V
authors.lastname: Catzola
authors.forename: Alessandra
authors.initials: A
authors.lastname: Battaglia
authors.forename: Alexia
authors.initials: A
authors.lastname: Buzzonetti
authors.forename: Marco
authors.initials: M
authors.lastname: Fossati
authors.forename: Flavia
authors.initials: F
authors.lastname: Scuderi
authors.forename: Andrea
authors.initials: A
authors.lastname: Fattorossi
authors.forename: Amelia
authors.initials: A
authors.lastname: Evoli
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000188:drug therapy* / Q000276:immunology; D020794:Receptor Protein-Tyrosine Kinases / Q000276:immunology; D011950:Receptors, Cholinergic / Q000276:immunology; D000069283:Rituximab; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D011950:Receptors, Cholinergic; D000069283:Rituximab; C095714:MUSK protein, human; D020794:Receptor Protein-Tyrosine Kinases